4-Chloromethyl-5-methyl-1,3-dioxol-2-one: Your Key Pharmaceutical Intermediate for Advanced Drug Synthesis

Discover the essential role of 4-Chloromethyl-5-methyl-1,3-dioxol-2-one (CAS 80841-78-7) in the pharmaceutical industry. As a leading manufacturer and supplier in China, we provide high-purity intermediates vital for developing life-saving medications. Explore our product details and secure your supply chain.

Get a Quote & Sample

Advantages of Sourcing Your Chemical Intermediates With Us

High Purity and Consistent Quality

Our 4-Chloromethyl-5-methyl-1,3-dioxol-2-one consistently meets ≥99.0% purity standards, crucial for sensitive pharmaceutical synthesis. As a reliable manufacturer, we guarantee batch-to-batch consistency for your R&D and production.

Versatile Pharmaceutical Applications

This intermediate is essential for synthesizing blockbuster drugs like Olmesartan Medoxomil and plays a role in ampicillin prodrugs. Leverage our product to advance your pharmaceutical development pipeline.

Reliable Supply and Competitive Pricing

Benefit from our significant production capacity and competitive pricing for this pharmaceutical intermediate. When you purchase from our facility in China, you secure a stable supply chain for your critical raw materials.

Key Applications in Pharmaceutical Development

Olmesartan Medoxomil Synthesis

The primary application of 4-Chloromethyl-5-methyl-1,3-dioxol-2-one is as a crucial intermediate in the synthesis of Olmesartan Medoxomil, an important antihypertensive drug.

Ampicillin Prodrug Preparation

This chemical compound also serves as a valuable reagent in the preparation of prodrugs for ampicillin, enhancing drug delivery and efficacy.

Research and Development

For R&D purposes, this intermediate is highly sought after by scientists and formulators seeking to develop novel pharmaceutical compounds and improve existing drug formulations.

Custom Synthesis Projects

As a versatile chemical building block, it can be utilized in various custom synthesis projects within the fine chemical and pharmaceutical sectors.